Generic Flomax Approved for Benign Prostatic Hyperplasia
Tamsulosin hydrochloride capsules approved by FDA to treat BPH
TUESDAY, March 2 (HealthDay News) -- The first generic version of Flomax (tamsulosin hydrochloride) capsules has been approved by the U.S. Food and Drug Administration to treat benign prostatic hyperplasia (BPH).
California-based IMPAX Laboratories will be producing the generic version, which will have the same prescribing information and safety warnings as the brand-name capsules, the FDA said in a news release.
BPH affects more than half of men in their 60s and as many as 90 percent of men older than 70, the agency said. Common symptoms include weak urine stream, urgency, leaking or dribbling, and more frequent urination -- often at night.
To learn more about enlarged prostate, visit the U.S. National Kidney and Urologic Diseases Information Clearinghouse.